Donafenib for Recurrent Cervical Cancer

Clinical trial NCT05310331 · UNKNOWN

Trial details

NCT number: NCT05310331
Sponsor: Lei Li
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Targeted Therapy Chemotherapy Recurrent Cervical Carcinoma Metastatic Cervical Carcinoma Persistent Advanced Cervical Carcinoma Survival Outcomes Adverse Effect

Start date: 2022-03-27
Primary completion: 2023-12-27
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.